Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy

M K Johnson1

  • 1MRC Toxicology Unit, University of Leicester, UK.

Insights

Neuropathy Target Esterase (NTE) is identified as the target of organophosphate-induced delayed neuropathy (OPIDP). Research clarifies the two-step aging process of NTE inhibition, aiding toxicological evaluations, though its biological function remains under investigation.

Area of Science:

  • Neurotoxicology
  • Biochemistry
  • Enzymology

Background:

  • Organophosphate-induced delayed neuropathy (OPIDP) is a neurotoxic disorder.
  • Neuropathy Target Esterase (NTE) was identified as the molecular target of OPIDP.
  • The precise biological function of NTE has remained elusive.

Purpose of the Study:

  • To introduce a symposium focused on Neuropathy Target Esterase (NTE).
  • To summarize the identification of NTE as the target of OPIDP.
  • To discuss the current understanding and future directions regarding NTE's function and inhibition.

Main Methods:

  • Review of studies involving organophosphates, phosphinates, and phosphonates.
  • Characterization of the two-step 'NTE aging' process.
  • Analysis of structure-activity relationships for neuropathic potential.

Main Results:

  • A two-step mechanism ('NTE aging') involving phosphylation and subsequent bond cleavage explains NTE inhibition.
  • This mechanism is crucial for understanding OP ester neuropathic potential and is used in regulatory toxicology.
  • Evidence suggests NTE inhibitors may act as partial agonists, and a related enzyme ('cousin-of NTE') may be involved in axonal damage response or repair.

Conclusions:

  • The 'NTE aging' model provides a framework for understanding OP-induced neurotoxicity.
  • While NTE's function is still unknown, research is progressing towards its isolation and functional characterization.
  • Emerging evidence points to a broader role for NTE and related enzymes in neuronal health and damage repair.